Sundaram Mutual Fund bought 1,70,000 shares of Gland Pharma Limited for ₹48.05 Cr at ₹2826.60 apiece in a block deal.
A vertically integrated injectable-focused pharmaceutical company, Gland Pharma develops, manufactures, and markets complex injectables for global markets across the United States, Europe, Canada, Australia, and India. Established in Hyderabad in 1978, the company operates on a business-to-business model and serves customers in over 60 countries worldwide. Known for its expertise in complex injectable formulations, it maintains a strong presence across the value chain. Gland Pharma is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Chennai-based AMC founded in 1996 as a joint venture with BNP Paribas, now wholly owned by the Sundaram Finance Group. Manages over Rs 1 lakh crore. Strong brand in South India with equity funds that have delivered consistent long-term track records across market cycles. Sundaram Mid Cap Fund has been a flagship since the early 2000s.